Robert Thomas Freeman, Chief Financial Officer at Alignment Healthcare, Inc. (ALHC), sold 48,800 shares at $10.11 ($533K) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Scheduled sale ($533k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.11 | 12,200 | $123K | 23.1% |
| 2 | $11.38 | 9,175 | $104K | 19.6% |
| 3 | $11.38 | 9,175 | $104K | 19.6% |
| 4 | $11.01 | 9,125 | $100K | 18.8% |
| 5 | $11.01 | 9,125 | $100K | 18.8% |
| Total | $10.92 avg | 48,800 |
| $533K |
| 100% |
| Filing → |
| ALHC | SELL | 2025-03-13 | $450K | — | Filing → |
| ALHC | SELL | 2025-03-06 | $10.7M | — | Filing → |
| ALHC | SELL | 2024-11-13 | $409K | — | Filing → |